Evidence map›Paper›PMID 26416908›Full record

ArticleInfection and immunity2015

Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages.

Ryan Finethy, Ine Jorgensen, Arun K Haldar, Marcel R de Zoete, Till Strowig, Richard A Flavell, Masahiro Yamamoto, Uma M Nagarajan, Edward A Miao, Jörn Coers

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An overview of human inflammasomes: Activation and regulation.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Infection and immunity · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. AIM2 sensors mediate immunity toProceedings of the National Academy of Sciences of the United States of America · 2023
    Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Ryan FinethyDepartments of Molecular Genetics and Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Ine JorgensenDepartment of Microbiology and Immunology and Lineberger Comprehensive Cancer Center, and Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, North Carolina, USA.
Arun K HaldarDepartments of Molecular Genetics and Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Marcel R de ZoeteDepartment of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Till StrowigDepartment of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA Helmholtz Center for Infection Research, Braunschweig, Germany.
Richard A FlavellDepartment of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Masahiro YamamotoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Yamadaoka, Suita, Osaka, Japan.
Uma M NagarajanDepartment of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Edward A MiaoDepartment of Microbiology and Immunology and Lineberger Comprehensive Cancer Center, and Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, North Carolina, USA.
Jörn CoersDepartments of Molecular Genetics and Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina, USA jorn.coers@duke.edu.
University of North Carolina at Chapel Hill · USDuke Medical Center · USDuke University · USDuke University Hospital · USHelmholtz Centre for Infection Research · DEHoward Hughes Medical Institute · USOsaka University · JPYale University · US

Funding

ORGANIZATION AND FUNCTIONS OF CELLULAR STRUCTUREST32GM007184 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1985 to 2019
$18.2M
IRGM-driven host responses to Chlamydia trachomatis infectionsR01AI103197 · NIAID · DUKE UNIVERSITY · PI COERS, JOERN · 2013 to 2023
$4.2M
Inflammasome Response to Bacterial InfectionR01AI097518 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MIAO, EDWARD A · 2012 to 2016
$2.0M
Role of caspase-11 in innate immunityR01AI119073 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MIAO, EDWARD A · 2015 to 2019
$1.7M
Interferon-inducible cell-intrinsic host defense against Chlamydia trachomatisR37AI103197 · NIAID · DUKE UNIVERSITY · PI Jorn Coers · 2024 to 2026
$1.6M
NIAID NIH HHS R01 AI097518NIAID NIH HHS R01 AI103197NIAID NIH HHS R01AI103197NIAID NIH HHS R01 AI119073NIAID NIH HHS R37 AI103197NIGMS NIH HHS T32 GM007184
6 · The paper itself

Abstract

Interferon (IFN)-inducible guanylate binding proteins (GBPs) mediate cell-autonomous host resistance to bacterial pathogens and promote inflammasome activation. The prevailing model postulates that these two GBP-controlled activities are directly linked through GBP-dependent vacuolar lysis. It was proposed that the rupture of pathogen-containing vacuoles (PVs) by GBPs destroyed the microbial refuge and simultaneously contaminated the host cell cytosol with microbial activators of inflammasomes. Here, we demonstrate that GBP-mediated host resistance and GBP-mediated inflammatory responses can be uncoupled. We show that PVs formed by the rodent pathogen Chlamydia muridarum, so-called inclusions, remain free of GBPs and that C. muridarum is impervious to GBP-mediated restrictions on bacterial growth. Although GBPs neither bind to C. muridarum inclusions nor restrict C. muridarum growth, we find that GBPs promote inflammasome activation in C. muridarum-infected macrophages. We demonstrate that C. muridarum infections induce GBP-dependent pyroptosis through both caspase-11-dependent noncanonical and caspase-1-dependent canonical inflammasomes. Among canonical inflammasomes, we find that C. muridarum and the human pathogen Chlamydia trachomatis activate not only NLRP3 but also AIM2. Our data show that GBPs support fast-kinetics processing and secretion of interleukin-1β (IL-1β) and IL-18 by the NLRP3 inflammasome but are dispensable for the secretion of the same cytokines at later times postinfection. Because IFN-γ fails to induce IL-1β transcription, GBP-dependent fast-kinetics inflammasome activation can drive the preferential processing of constitutively expressed IL-18 in IFN-γ-primed macrophages in the absence of prior Toll-like receptor stimulation. Together, our results reveal that GBPs control the kinetics of inflammasome activation and thereby shape macrophage responses to Chlamydia infections.

Indexed as

AnimalsCarrier ProteinsCaspasesCaspases, InitiatorChlamydia InfectionsChlamydia muridarumChlamydia trachomatisDNA-Binding ProteinsFibroblastsGene Expression RegulationGTP-Binding ProteinsHost-Pathogen InteractionsInclusion BodiesInflammasomesInterferon-gammaInterleukin-18AIM2 protein, humanCarrier ProteinsCasp4 protein, mouseCaspasesCaspases, InitiatorDNA-Binding ProteinsGbp2b protein, mouseGbp2 protein, mouseGTP-Binding ProteinsInflammasomesInterferon-gammaInterleukin-18Interleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, human

Identifiers

PMID26416908
PMCPMC4645370
OpenAlexW2191218497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.